Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wang, Fu ^a,b   Song, Xinxing ^b   Li, Xiujuan ^b   Xin, Jing ^a   Wang, Shenxu ^b   Yang, Weidong ^b   Wang, Jing ^b   Wu, Kaichun ^b   Chen, Xiaoyuan ^c   Liang, Jimin ^a   Tian, Jie ^a,d   Cao, Feng ^b  

^a XIDIAN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^d INSTITUTE OF AUTOMATION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IODINE 131; MICRORNA 16; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTECHNETIC ACID TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CANCER RESISTANCE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DUAL IMAGING REPORTER GENE SYSTEM; FEMALE; FLUC GENE; FUSION GENE; GENE ACTIVITY; GENE EXPRESSION; HNIS GENE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; RADIOACTIVITY; REPORTER GENE; STOMACH CANCER; TRANSGENE; UPREGULATION;

ANIMALS; CELL COUNT; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HERPES SIMPLEX VIRUS PROTEIN VMW65; HUMANS; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MICE, NUDE; MICRORNAS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SYMPORTERS; TRANSGENES; UP-REGULATION;

EID: 84876274984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061792     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20.
3. Rivera F, Vega-Villegas ME, Lopez-Brea MF, (2007) Chemotherapy of advanced gastric cancer. Cancer Treat Rev 33: 315-324.
4. Broxterman HJ, Gotink KJ, Verheul HM, (2009) Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat 12: 114-126.
5. Baguley BC, (2010) Multiple drug resistance mechanisms in cancer. Mol Biotechnol 46: 308-316.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Allen KE, Weiss GJ, (2010) Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 9: 3126-3136.
8. Ma J, Dong C, Ji C, (2010) MicroRNA and drug resistance. Cancer Gene Ther 17: 523-531.
9. Sarkar FH, Li Y, Wang Z, Kong D, Ali S, (2010) Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13: 57-66.
10. Zheng T, Wang J, Chen X, Liu L, (2010) Role of microRNA in anticancer drug resistance. Int J Cancer 126: 2-10.
11. Xia L, Zhang D, Du R, Pan Y, Zhao L, et al. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379.
12. Blasberg RG, Gelovani-Tjuvajev J, (2002) In vivo molecular-genetic imaging. J Cell Biochem Suppl 39: 172-183.
13. Jo MH, Ali BA, Al-Khedhairy AA, Lee CH, Kim B, et al. (2012) A reverse complementary multimodal imaging system to visualize microRNA9-involved neurogenesis using peptide targeting transferrin receptor-conjugated magnetic fluorescence nanoparticles. Biomaterials 33: 6456-6467.
14. Kang WJ, Cho YL, Chae JR, Lee JD, Ali BA, et al. (2012) Dual optical biosensors for imaging microRNA-1 during myogenesis. Biomaterials 33: 6430-6437.
15. Kim JK, Choi KJ, Lee M, Jo MH, Kim S, (2012) Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials 33: 207-217.
16. Wang F, Niu G, Chen X, Cao F, (2011) Molecular imaging of microRNAs. Eur J Nucl Med Mol Imaging 38: 1572-1579.
17. Boldt S, Weidle UH, Kolch W, (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23: 1831-1838.
18. Li F, Sethi G, (2010) Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 1805: 167-180.
19. Massoud TF, Gambhir SS, (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545-580.
20. Kang JH, Chung JK, (2008) Molecular-genetic imaging based on reporter gene expression. J Nucl Med 49 (Suppl 2):: 164S-179S.
21. Chung JK, (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43: 1188-1200.
22. Fang JY, Richardson BC, (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6: 322-327.
23. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, et al. (2003) Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278: 19245-19256.
24. Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, et al. (1994) Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 269: 7030-7035.
25. Yang SY, Miah A, Sales KM, Fuller B, Seifalian AM, et al. (2011) Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Int J Oncol 38: 1695-1702.